reproductive-health
(7)
Joshua Abram
Joshua Abram was a serial entrepreneur and investor who spent two decades building category-defining, venture-backed companies across technology, hospitality, and life sciences. With his longtime partner Alan Murray, he co-founded Integral Ad Science, the workplace brand NeueHouse, the data-science firm Dstillery, and the fertility-technology companies TMRW Life Sciences and Conceivable Life Sciences. At Conceivable he set out to build the world's first fully automated IVF laboratory, AURA, with the aim of turning a Nobel Prize-winning therapy into a population-scale, lower-cost solution. He was named to Goldman Sachs' list of the 100 Most Intriguing Entrepreneurs in 2021 and died in August 2025 at age 62.
Tara Raffi
Tara Raffi is the founder and CEO of Almond ObGyn, a venture-backed, tech-enabled women's health practice she co-founded with Carly Allen in 2021. A former McKinsey consultant who built the firm's $50M internal tech incubator and was an early operations and marketing hire at the location-data company Factual, she started Almond after years of frustrating personal experiences trying to book gynecological care. Backed by Y Combinator (S22), True Ventures and others with a $7M seed round, Almond pitches itself as 'One Medical for women's health,' combining in-person LA clinics with telehealth. Raffi and Allen were named to Inc.'s 2024 Female Founders 250 list.
Angela Rastegar
Angela Rastegar is the co-founder and CEO of Sunfish, a Los Angeles fertility-finance company that treats the cost of building a family as a problem worth engineering around. After a 2016 egg-freezing attempt left her facing a confusing, expensive and isolating bill with no insurance to lean on, she went to work inside the fertility industry, watched patients drain 401(k)s and sell engagement rings, and then built a platform of loans, grants, guidance and a money-back IVF Success Program priced off a patient's own biodata. A two-time founder with a Stanford biology degree and a Stanford MBA, she raised a $10M Series A in early 2025 and put a refund guarantee at the center of an industry that has long charged for attempts rather than outcomes.
Evan Sussman
Evan Sussman is the co-founder and CEO of Granata Bio, a Boston-based biopharma company expanding access to fertility care by in-licensing IVF medications proven abroad and bringing them through U.S. clinical development and commercialization. A former fertility business unit head at EMD Serono, he built Granata to be revenue-positive early through a fee-for-service model, then raised a $14M Series A led by GV (Google Ventures), extended it, acquired ovarian-aging biotech Oviva Therapeutics, and struck a strategic investment and co-development deal with Gedeon Richter.
Sophia Yen
Dr. Sophia Yen, MD, MPH is the CEO and Co-Founder of Pandia Health, the only women-founded, women-led, doctor-founded, physician-led birth control and menopause telemedicine and medication delivery service in the United States. A Clinical Associate Professor of Pediatrics at Stanford Medical School with 20+ years in medicine, she brings MIT engineering instincts, UCSF medical training, and UC Berkeley public health expertise to the problem of making prescription contraceptives and hormonal care radically more accessible for women. She co-founded SheHeroes.org to inspire girls in STEM and has been a nationally recognized voice on reproductive rights, menstrual equity, and women's health innovation.
Sylvia Kang
Sylvia Kang is the CEO and co-founder of Mira (Miracare), the company behind the world's first FDA and CE-registered comprehensive at-home hormone monitoring platform. A former concert pianist who pivoted to biomedical engineering, she built Mira from her kitchen table into a 140-person company with 200,000+ users worldwide and over 50,000 women helped to conceive naturally. Named to Inc. Magazine's 2024 Female Founders 250 list and Femtech World's Leader of the Year, Kang holds an MS in Biomedical Engineering from Columbia and an MBA from Cornell, and used her own product to conceive after age 35.
Paxton Maeder-York
Paxton Maeder-York is the founder of Alife Health, an AI platform for IVF clinics that has raised $31.5M and raised the standard for data-driven fertility care. A Harvard-trained biomedical engineer and MBA, he previously helped build surgical robotics at Auris Health (acquired by J&J for $3.4B) and worked in product at Google X. In 2020, driven in part by the fact that his younger brother is an IVF baby, he founded Alife to apply machine learning to embryo selection, hormone dosing, and lab scheduling. By 2024 the company had launched five products, earned recognition from Fast Company and the World Economic Forum, and achieved a leadership transition - Paxton stepping into a board role as Melissa Teran took the CEO seat.